期刊文献+

重组γ干扰素的表达与纯化 被引量:3

Expression and purification of recombinant interferon-gamma
下载PDF
导出
摘要 目的 探讨γ干扰素在大肠杆菌中的表达及纯化方法 ,为下一步批量生产提供实验依据。方法 应用DNA重组技术把中国人淋巴细胞mRNA反转录产物IFN -γcDNA克隆到原核表达质粒 pBV2 2 0上 ,构建出pBVIFN高效表达载体 ,转化大肠杆菌 plyss。通过温度诱导 ,高效表达IFN -γcDNA。然后 ,经过包涵体溶解、复性、浓缩及DEAE离子交换层析 ,使γ干扰素纯化。结果 IFN -γcDNA表达水平占菌体可溶性蛋白的 40 4% ,包涵体纯度为 70 % ,总生物活性为 1 2 7× 10 9U ,比活性达 1.31× 10 9U/L蛋白 ,活性回收率为 77.7%。 Objective To research interferon-gamma expression and purification methods in E.coli and provide experimental basis for further lots of production. Methods Using DNA recombinant technology,IFN-γ cDNA,which reversed transcription from Chinese lymphocyte mRAN, was cloned to the prokaryotic expression plasmid pBV220 and was constructed pBVIFN of efficient expression vector, then transferred into E.coli plyass.IFN-γ can be expressed efficiently by termoinduction. By the inclusion bodies dissolution, renaturation,concentration and DEAE ion exchange chromatography IFN-γ was purified. Results The IFN-γ expression yield was 40 4% of bacterial soluble proteins. The purification of the inclusion bodise was 70%. The total biological activity was 1 27×10 9 U.The specific activity was 1 31×10 9 U/L.The activity recovery rate was 77.7%. Conclusion The experiment method will lay a foundation for lots of production of the interferon-gamma.
出处 《山西医科大学学报》 CAS 2000年第4期289-291,共3页 Journal of Shanxi Medical University
基金 山西省科技攻关项目!(940 81)
关键词 重组γ干扰素 分子克隆 重组DNA interferon-gamma,recombinant DNA,recombinant cloning,molecular
  • 相关文献

参考文献5

二级参考文献6

  • 1张智清,病毒学报,1988年,4卷,94页
  • 2鱼咏涛,高技术通讯,1993年,3卷,27页
  • 3贺福初,科学通报,1993年,38卷,1323页
  • 4张智清,病毒学报,1990年,6卷,111页
  • 5张智清,侯云德,李玉英,赵小侠,周园,段淑敏,姚立红.应用P_RP_L串联启动子和CIts857调控基因高效表达人γ干扰素[J]病毒学报,1988(02).
  • 6张德震,吴淑华,侯云德,苏成芝.重组人γ干扰素的纯化[J].病毒学报,1989,5(1):37-40. 被引量:22

共引文献28

同被引文献27

  • 1董宁征,吴庆宇,潘峻亮,阮长耿.dsPAα1的缺失突变体的构建及其活性[J].中国生物化学与分子生物学报,2004,20(6):805-809. 被引量:2
  • 2王艳艳,王革,乔刚,王君艳,刘建峰,陈冠军.溶栓新药瑞替普酶包涵体纯化和变性条件的研究[J].山东大学学报(理学版),2005,40(4):122-124. 被引量:3
  • 3袁伯俊,方裕强,刘俊平,陆国才,杨幼明,周光兴.人重组γ干扰素对大鼠和狗的毒性(英文)[J].中国药理学报,1995,16(4):308-310. 被引量:1
  • 4贺平,何诚,张华,宋后燕,朱运松.大肠杆菌表达的重组人PAI-1的纯化[J].生物化学杂志,1996,12(6):729-734. 被引量:2
  • 5Trinh R, Gurbaxani B, Morrison SL, et al. Optimization of codon pair use within the (GGGGS)3 linker sequence results in enhanced protein expression[J ]. Mol Immunol, 2004, 40(10):717
  • 6Bode C, Nordt T K, Runge M S. Thrombolytic therapy in acute myoxardial infarction-selected recent developments. Ann Hematol, 1994,69(4) : S35-40.
  • 7Schleuning W D, Alagon A, Boidol W, et al. Plasminogen activators from the saliva of Desmodus rotundus (common vampire bat) : unique fibrin specificity. Ann N Y Acad Sci, 1992,667 : 395-403.
  • 8Hildebrand M, Bhargava A S, Bringmann P, et al. Pharmacokinetics of the novel plasminogen activator Desmodus rotundus plasminogen activator in animals and extrapolation to man. Fibrinolysis, 1996,10(5-6) : 269-2763.
  • 9Kratzschmar J, Haendler B, Langer G, et al. The plasminogen activator family from the salivary gland of the vampire bat Desmodus rotundus: cloning and expression. Gene, 1991, 105(2) : 229-237.
  • 10Petri T, Langer G, Bringmann P, et al. Production of vampire bat plasminogen activator DSPA alpha 1 in CHO and insect cells. J Biotechnol, 1995,39(1) : 75-83.

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部